The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Italian observational study in patients with metastatic colorectal cancer (mCRC) treated with first-line cetuximab based regimen (ObservEr study).
Francesca Di Fabio
No relevant relationships to disclose
Gerardo Rosati
No relevant relationships to disclose
Ivan Roberto Lolli
No relevant relationships to disclose
Enzo Maria Ruggeri
No relevant relationships to disclose
Libero Ciuffreda
No relevant relationships to disclose
Daris Ferrari
No relevant relationships to disclose
Salvatore Tumolo
No relevant relationships to disclose
Giovanni Rosti
No relevant relationships to disclose
Paolo Tralongo
No relevant relationships to disclose
Raimondo Ferrara
No relevant relationships to disclose
Oscar Alabiso
No relevant relationships to disclose
Silvana Chiara
No relevant relationships to disclose
Giovanni Paolo Ianniello
No relevant relationships to disclose
Francesco Di Costanzo
No relevant relationships to disclose
Antonio Frassoldati
No relevant relationships to disclose
Carmelo Iacono
No relevant relationships to disclose
Mario Clerico
No relevant relationships to disclose
Lorenzo Pavesi
No relevant relationships to disclose
Giovanni Bernardo
No relevant relationships to disclose
Carmine Pinto
No relevant relationships to disclose